Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

THIS IS HOW A DRUG IS TOWED TO THE BRAIN

Media & Press, News
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansión

Sometimes drugs need a special push to be more effective and reach its final destination: the brain. The three families of peptides (proteins) developed and patented by Gate2Brain fullfil that mission by acting as a shuttle or tractor so that the medicines act on this organ and treat pathologies located in it. This development, after years of work, has been possible thanks to a team of researchers and professionals from the Universitat de Barcelona, ​​the IRB Barcelona and the Hospital Sant Joan de Déu Barcelona, led by Meritxell Teixido, CEO of Gate2Brain.

“The first application of this technology will be for the treatment of pediatric cancer, when it is located in the brain. We are currently in the preclinical phase and the first clinical trial with pediatric patients is scheduled for 2026 at the Sant Joan de Déu Hospital, a reference center for childhood diseases”, explains Teixidó. However, the applications of these tractors are more ambitious and, as this researcher points out, they could serve to improve the transport of other drugs to the brain to address diseases such as Parkinson’s or Alzheimer’s: “The idea is to reach agreements with large pharmaceutical companies to test our technology with their drug candidates”, she adds.

 

Source: https://www.expansion.com

December 19, 2022/by noticias
Tags: Expansión, Gate2Brain, pediatriccancer, research, Startup
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/12/Gradient-Professional-Linkedin-Profile-Picture-2.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-12-19 18:18:392025-02-19 09:38:09THIS IS HOW A DRUG IS TOWED TO THE BRAIN
You might also like
Grit International Female Accelerator!Grit International Female AcceleratorG2B joined the Grit International Female Accelerator
G2B at Pediatric Diffuse Midline Glioma International Meeting
Gate2Brain and its “molecular tractors” technology: new way to optimize the transport of drugs to the brain
Sustainability Policies, Innovation, Entrepreneurship and New Production Models.g2bSustainability Policies, Innovation, Entrepreneurship and New Production Models
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
la start-up catalana una de las ganadoras del South Summit de salud en Valenciala VanguardiaGate2Brain one of the winners of the South Summit Health & Well-being
Una tecnología para ayudar a tratar el cáncer infantilgate2brainA technology to help treat pediatric cancer
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain Selected for the EU Business Hub Mission at World Health Expo Osaka 2026June 23, 2026 - 13:31
  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Three University of Barcelona spin-offs receive funding from Women TechEUThree University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaTeam Sant Joan de DeuGate2Brain receives €2,5M funding from EIC to develop its technology
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}